Novartis — East Hanover, New Jersey

Novartis is a clinical research site located in East Hanover, New Jersey, United States 07936.

Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.

Novartis has participated in 81 clinical trials with 5 currently active.

Therapeutic areas: Advanced Non-small Cell Lung Cancer and MET Exon 14 Skipping Mutation, Dyspepsia, Tuberculosis.

Sponsors: Novartis Pharmaceuticals, Novartis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Hanover

Browse all research sites in New Jersey · View every site in East Hanover

• Beth Israel Hospital
• Novartis Pharmaceuticals
• Novartis Investigative Site
• Kessler Foundation
• sites in USA
• Novartis Pharmaceuticals Corporation
• Novartis Investigational site
• Investigative Site
• Novartis USA
• For US Site Information, contact Novartis Pharmaceuticals
• For information regarding facilities, please contact the Central Contact

Sponsor Feasibility Report

Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis?

Novartis has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis conducted?

Novartis has 81 clinical trials on record, with 5 currently active. Their work covers Advanced Non-small Cell Lung Cancer and MET Exon 14 Skipping Mutation, Dyspepsia, Tuberculosis.

Is Novartis accredited by Crixeo Clinical Trials?

Novartis has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.